Reimbursed with a limitationOriginator productATC A16AA04

Procysbi

Procysbi is an originator product from Chiesi SA and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 374.50 to CHF 4'492.40 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Chiesi SA
ATC code
A16AA04
IT group
07.99 Varia
Active substances
Mercaptaminum
Preparation type
Originator product
On the SL since
01/07/2024
Last price change
01/07/2024
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Procysbi Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Kaps 25 mgFl 60 StkCHF 329.25CHF 374.5001/07/2024B7680671290011
Kaps 75 mgFl 250 StkCHF 4'115.63CHF 4'492.4001/07/2024B7680671290028

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/07/2024

Die Anwendung von PROCYSBI hat gemäss den Angaben der von Swissmedic genehmigten Fachinformation zu erfolgen:
Die Einleitung der PROCYSBI-Therapie sollte unter der Kontrolle eines Arztes erfolgen, der über Erfahrung in der Behandlung von Cystinose verfügt.
Die Mercaptamin-Therapie muss umgehend nach Bestätigung der Diagnose einer nephropathischen Cystinose (d.h. anhand eines erhöhten leukozytären Cystingehaltes) eingeleitet werden, damit ein höchstmöglicher therapeutischer Nutzen erreicht wird.
Nach Kostengutsprache durch den Krankenversicherer bzw. durch die IV-Stelle nach vorgängiger Konsultation des RAD.

FAQ

Is Procysbi covered by Swiss health insurance?

Yes, but only under conditions. Procysbi is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Procysbi cost in Switzerland?

The public price is the maximum price set by the FOPH and for Procysbi ranges from CHF 374.50 to CHF 4'492.40 per pack. The ex-factory price ranges from CHF 329.25 to CHF 4'115.63. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com